1124 - Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients

Rapid Fire Presenter(s)

• 

  Antonio C. Arrieta, MD, FIDSA, FPIDS

  Medical Director, Pediatric Infectious Disease
  Children's Hospital of Orange County
  Orange, CA, United States

Co-Author(s)

• HS

  Heidi Segers, MD, PhD

  University Hospitals Leuven and Catholic University Leuven, Leuven, Belgium
  Leuven, Vlaams-Brabant, Belgium
• JD

  Jaime G. Deville, MD

  Professor of Clinical Infectious Diseases
  University of California, Los Angeles, California, USA
  Los Angeles, California, United States
• WM

  William J. Muller, MD, PhD

  Associate Professor
  Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA
  Chicago, Illinois, United States
• AM

  Angela Manzanares, MD

  Hospital Universitario 12 de Octubre, Madrid, Spain
  Madrid, Madrid, Spain
• 

  Michael N. Neely, MD

  Pediatric Infectious Diseases
  The Saban Research Institute, Children’s Hospital Los Angeles, University of Southern California, Los Angeles, CA, USA
  Los Angeles, California, United States
• VB

  Victoria Bordon, MD, PhD

  Ghent University Hospital, Ghent, Belgium
  Ghent, Oost-Vlaanderen, Belgium
• 

  Benjamin Hanisch, MD

  Assistant Professor
  Children’s National Hospital, Washington, DC, USA
  Washington, District of Columbia, United States
• AL

  Alvaro Lassaletta, MD, PhD

  Hospital Infantil Universitario Niño Jesús, Madrid, Spain
  Madrid, Madrid, Spain
• 

  Brian T. Fisher, DO, MPH/MSCE (he/him/his)

  Associate Chair of Research
  Children’s Hospital of Philadelphia
  Philadelphia, PA, United States
• JA

  Julie Autmizguine, MD, MHS

  Université de Montréal, Quebec, Canada
  Montreal, Quebec, Canada
• 

  Andreas H. Groll, MD

  Professor of Paediatrics, Head of the Infectious Disease Research Programme and Deputy Director of the Department of Haematology/Oncology
  University Children’s Hospital Muenster, Muenster, Germany
  Muenster, Nordrhein-Westfalen, Germany
• SS

  Shamim Sinnar, MD, PhD

  Astellas Pharma Global Development Inc., Northbrook, Illinois, USA
  Northbrook, Illinois, United States
• RC

  Rodney Croos-Dabrera, PhD

  Astellas Pharma Global Development Inc., Northbrook, Illinois, USA
  Northbrook, Illinois, United States
• ME

  Marc Engelhardt, MD

  Dr.
  Basilea Pharmaceutica International Ltd., Allschwil, Switzerland
  Allschwil, Basel-Landschaft, Switzerland
• MJ

  Mark E. Jones, PhD

  Basilea Pharmaceutica International Ltd., Allschwil, Switzerland
  Allschwil,, Basel-Landschaft, Switzerland
• LK

  Laura Kovanda, PhD

  Senior Director
  Astellas Pharma Global Development Inc., Northbrook, Illinois, USA
  Northbrook, Illinois, United States